Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 -0.00105152471083068 -0.021030494216614
Stock impact report

Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 ASHG Annual Meeting

Aeglea BioTherapeutics, Inc. (AGLE) 
Last aeglea biotherapeutics, inc. earnings: 8/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aegleabio.com/investor-overview
Company Research Source: GlobeNewswire
  Company to Host Clinical Update Conference Call on October 17 at 8:30 a.m. ET Aeglea to Present Literature Review on Arginase 1 Deficiency Positive Preclinical Efficacy Data on its AEB4104 Homocystinuria Therapeutic Program AUSTIN, Texas, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer, today announced it will present new interim Phase 1/2 clinical trial data demonstrating clinical improvement in patients with Arginase 1 Deficiency at the 2018 American Society of Human Genetics (ASHG) Annual Meeting being held October 16 – 20 in San Diego, California. The Company will hold a clinical update conference call on October 17 at 8:30 a.m. ET to discuss these developments. Title: Improvements in Arginase 1 Deficiency-related disease manifestations following plasma arginine reduction with pegzilarginase: Show less Read more
Impact Snapshot
Event Time:
AGLE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AGLE alerts
Opt-in for
AGLE alerts

from News Quantified
Opt-in for
AGLE alerts

from News Quantified